Vascular cognitive impairment

John T. O'Brien, Timo Erkinjuntti, Barry Reisberg, Gustavo Roman, Tohru Sawada, Leonardo Pantoni, John V. Bowler, Clive Ballard, Charles DeCarli, Philip B. Gorelick, Kenneth Rockwood, Alistair Burns, Serge Gauthier, Steven T. DeKosky

Research output: Contribution to journalArticle

854 Citations (Scopus)

Abstract

Cerebrovascular disease is the second most common cause of acquired cognitive impairment and dementia and contributes to cognitive decline in the neurodegenerative dementias. The current narrow definitions of vascular dementia should be broadened to recognise the important part cerebrovascular disease plays in several cognitive disorders, including the hereditary vascular dementias, multi-infarct dementia, post-stroke dementia, subcortical ischaemic vascular disease and dementia, mild cognitive impairment, and degenerative dementias (including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies). Here we review the current state of scientific knowledge on the subject of vascular brain burden. Important non-cognitive features include depression, apathy, and psychosis. We propose use of the term vascular cognitive impairment, which is characterised by a specific cognitive profile involving preserved memory with impairments in attentional and executive functioning. Diagnostic criteria have been proposed for some subtypes of vascular cognitive impairment, and there is a pressing need to validate and further refine these. Clinical trials in vascular cognitive impairment are in their infancy but support the value of therapeutic interventions for symptomatic treatment.

Original languageEnglish (US)
Pages (from-to)89-98
Number of pages10
JournalLancet Neurology
Volume2
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Blood Vessels
Vascular Dementia
Dementia
Cerebrovascular Disorders
Multi-Infarct Dementia
Lewy Body Disease
Apathy
Frontotemporal Dementia
Vascular Diseases
Psychotic Disorders
Cognitive Dysfunction
Alzheimer Disease
Stroke
Clinical Trials
Depression
Brain

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

O'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., ... DeKosky, S. T. (2003). Vascular cognitive impairment. Lancet Neurology, 2(2), 89-98. https://doi.org/10.1016/S1474-4422(03)00305-3

Vascular cognitive impairment. / O'Brien, John T.; Erkinjuntti, Timo; Reisberg, Barry; Roman, Gustavo; Sawada, Tohru; Pantoni, Leonardo; Bowler, John V.; Ballard, Clive; DeCarli, Charles; Gorelick, Philip B.; Rockwood, Kenneth; Burns, Alistair; Gauthier, Serge; DeKosky, Steven T.

In: Lancet Neurology, Vol. 2, No. 2, 01.02.2003, p. 89-98.

Research output: Contribution to journalArticle

O'Brien, JT, Erkinjuntti, T, Reisberg, B, Roman, G, Sawada, T, Pantoni, L, Bowler, JV, Ballard, C, DeCarli, C, Gorelick, PB, Rockwood, K, Burns, A, Gauthier, S & DeKosky, ST 2003, 'Vascular cognitive impairment', Lancet Neurology, vol. 2, no. 2, pp. 89-98. https://doi.org/10.1016/S1474-4422(03)00305-3
O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L et al. Vascular cognitive impairment. Lancet Neurology. 2003 Feb 1;2(2):89-98. https://doi.org/10.1016/S1474-4422(03)00305-3
O'Brien, John T. ; Erkinjuntti, Timo ; Reisberg, Barry ; Roman, Gustavo ; Sawada, Tohru ; Pantoni, Leonardo ; Bowler, John V. ; Ballard, Clive ; DeCarli, Charles ; Gorelick, Philip B. ; Rockwood, Kenneth ; Burns, Alistair ; Gauthier, Serge ; DeKosky, Steven T. / Vascular cognitive impairment. In: Lancet Neurology. 2003 ; Vol. 2, No. 2. pp. 89-98.
@article{f1a199410d2c452f8ecbe33e7827aa7d,
title = "Vascular cognitive impairment",
abstract = "Cerebrovascular disease is the second most common cause of acquired cognitive impairment and dementia and contributes to cognitive decline in the neurodegenerative dementias. The current narrow definitions of vascular dementia should be broadened to recognise the important part cerebrovascular disease plays in several cognitive disorders, including the hereditary vascular dementias, multi-infarct dementia, post-stroke dementia, subcortical ischaemic vascular disease and dementia, mild cognitive impairment, and degenerative dementias (including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies). Here we review the current state of scientific knowledge on the subject of vascular brain burden. Important non-cognitive features include depression, apathy, and psychosis. We propose use of the term vascular cognitive impairment, which is characterised by a specific cognitive profile involving preserved memory with impairments in attentional and executive functioning. Diagnostic criteria have been proposed for some subtypes of vascular cognitive impairment, and there is a pressing need to validate and further refine these. Clinical trials in vascular cognitive impairment are in their infancy but support the value of therapeutic interventions for symptomatic treatment.",
author = "O'Brien, {John T.} and Timo Erkinjuntti and Barry Reisberg and Gustavo Roman and Tohru Sawada and Leonardo Pantoni and Bowler, {John V.} and Clive Ballard and Charles DeCarli and Gorelick, {Philip B.} and Kenneth Rockwood and Alistair Burns and Serge Gauthier and DeKosky, {Steven T.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1016/S1474-4422(03)00305-3",
language = "English (US)",
volume = "2",
pages = "89--98",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "2",

}

TY - JOUR

T1 - Vascular cognitive impairment

AU - O'Brien, John T.

AU - Erkinjuntti, Timo

AU - Reisberg, Barry

AU - Roman, Gustavo

AU - Sawada, Tohru

AU - Pantoni, Leonardo

AU - Bowler, John V.

AU - Ballard, Clive

AU - DeCarli, Charles

AU - Gorelick, Philip B.

AU - Rockwood, Kenneth

AU - Burns, Alistair

AU - Gauthier, Serge

AU - DeKosky, Steven T.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Cerebrovascular disease is the second most common cause of acquired cognitive impairment and dementia and contributes to cognitive decline in the neurodegenerative dementias. The current narrow definitions of vascular dementia should be broadened to recognise the important part cerebrovascular disease plays in several cognitive disorders, including the hereditary vascular dementias, multi-infarct dementia, post-stroke dementia, subcortical ischaemic vascular disease and dementia, mild cognitive impairment, and degenerative dementias (including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies). Here we review the current state of scientific knowledge on the subject of vascular brain burden. Important non-cognitive features include depression, apathy, and psychosis. We propose use of the term vascular cognitive impairment, which is characterised by a specific cognitive profile involving preserved memory with impairments in attentional and executive functioning. Diagnostic criteria have been proposed for some subtypes of vascular cognitive impairment, and there is a pressing need to validate and further refine these. Clinical trials in vascular cognitive impairment are in their infancy but support the value of therapeutic interventions for symptomatic treatment.

AB - Cerebrovascular disease is the second most common cause of acquired cognitive impairment and dementia and contributes to cognitive decline in the neurodegenerative dementias. The current narrow definitions of vascular dementia should be broadened to recognise the important part cerebrovascular disease plays in several cognitive disorders, including the hereditary vascular dementias, multi-infarct dementia, post-stroke dementia, subcortical ischaemic vascular disease and dementia, mild cognitive impairment, and degenerative dementias (including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies). Here we review the current state of scientific knowledge on the subject of vascular brain burden. Important non-cognitive features include depression, apathy, and psychosis. We propose use of the term vascular cognitive impairment, which is characterised by a specific cognitive profile involving preserved memory with impairments in attentional and executive functioning. Diagnostic criteria have been proposed for some subtypes of vascular cognitive impairment, and there is a pressing need to validate and further refine these. Clinical trials in vascular cognitive impairment are in their infancy but support the value of therapeutic interventions for symptomatic treatment.

UR - http://www.scopus.com/inward/record.url?scp=0038049262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038049262&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(03)00305-3

DO - 10.1016/S1474-4422(03)00305-3

M3 - Article

C2 - 12849265

AN - SCOPUS:0038049262

VL - 2

SP - 89

EP - 98

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 2

ER -